SENOTHERAPEUTICS FOR AGE MANAGEMENT MEDICINE
3.5 CME Credits – $195.00
Courses are Enduring Materials from a Clinical Applications for Age Management Medicine Conference
Poised to Become the Next Big Niche in Age Management Medicine. Cellular senescence is one of the main driving forces for aging and organ dysfunction. It is important for practitioners to understand how to assess body senescence burden and how to employ adequate senolytic strategies.
This course will teach healthcare practitioners the fundamentals for properly integrating senolytic treatments into their clinical practices.
Disclosure Statements
Planning Committee: All AMMG Planning Committee members
Faculty Disclosures: All AMMG Planning Committee members
Program Reviewers: Mary Corry, MSN and Dana Burnett, M. Ed. have no relevant financial relationships to disclose.
All relevant financial relationships for this event have been reviewed and mitigated.
Faculty/Planner Disclosures
Conference Planning Committee
Florence Comite, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Mary L. Corry, R.N. – No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Faculty
Christopher Arboleda, MS – No Relevant Relationships with a Commercial Interest to Disclose
Michale Barber, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John C. Carrozzella, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
William Clearfield, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Florence Comite, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Dana Delgardo, FNP – No Relevant Relationships with a Commercial Interest to Disclose
Carolyn DeLucia, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Angela DeRosa, D.O. – Belmar Pharma, Medical Director; Hormone Health Institute, Owner/ Founder
Derrick DeSilva, Jr., M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Elliott Dinetz, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Benjamin Gonzalez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Jonathan Keith, M.D., FACS – No Relevant Relationships with a Commercial Interest to Disclose
Dobri Kiprov, M.D. – Fresenius Medical Care, Stock or Stock Options
Edwin N. Lee, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Jeffry Life, M.D., Ph.D. – No Relevant Relationships with a Commercial Interest to Disclose
Ashley Madison – No Relevant Relationships with a Commercial Interest to Disclose
Luis Martinez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Kathy Maupin, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Abraham Morgenthaler, M.D. – Antares, Consultant; Acerus, Consultant; Bayer, Advisory Committee Member; Marius, Consultant; Endo, Research Gran
Beatriz Olsen, M.D., FACP – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Theresa Ramsey, NMD – No Relevant Relationships with a Commercial Interest to Disclose
Neal Rouzier, M.D. – Evexias, Speaker Bureau
Jodie Scholes – Green Sunshine, Ownership
Jin-Xiong She, Ph.D. – Jinfiniti Precision Medicine, Executive Role/Ownership
Jason Sonners, D.C., DCBCN – No Relevant Relationships with a Commercial Interest to Disclose
Paul Thompson, M.D. – Launch Medical, Executive Role, Organicel, Stock Options
Dushyant Viswanathan, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Payam Zand, M.D. – No Relevant Relationships with a Commercial Interest to Disclose